Background: Hepatitis B (HBV) and hepatitis C (HCV)virus infection is a major concern among tuberculous (TB) patients, thus early screening of these viruses will influence the outcome of the disease.
Methods: A cross-sectional hospital based study, conducted at Kassala teaching hospital, Eastern Sudan, between June and December 2014 to investigate the sero-prevalence of HBV and HCV among TB patients. Sera samples were collected from patients and tested for HBSAg and anti-HCV bodies using immunochromtogrophic test (ICT) and enzyme-link immunosorbantassay (ELISA).
Results: Out of 98 TB patients recruited in the study, HBSAg and anti HCV were detected in 15.3% and 1% patients using ELISA respectively, and in 17.3% and 3.1% patients by ICT respectively, one percent patient had both HBV and HCV co- infection.
Conclusion: The sero-prevalence of HBV and HCV shown in this study call for urgent need to consider HBV and HCV screening in the national TB control program as this may reduce the risk of hepatotoxicity occurring during treatment of TB.
Keywords:
Published on: Apr 10, 2015 Pages: 1-3
Full Text PDF
Full Text HTML
DOI: 10.17352/2455-5363.000001
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."